Medibank share price lifts despite shareholder class action

The health insurer has been hit with another class action relating to its 2022 cyber-attack.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price is gaining 0.76% to trade at $3.295 right now
  • That's despite news the company is facing a shareholder class action
  • The action alleges Medibank breached continuous disclosure obligations and ASX listing rules 

The Medibank Private Ltd (ASX: MPL) share price is in the green on Thursday despite the company facing a shareholder class action.

It comes on the back of a massive cyber-attack that saw the data of 9.7 million Australians in the hands of hackers late last year.

Right now, the Medicare share price is $3.295, 0.76% higher than its previous close.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has gained 0.97% at the time of writing.

Let's take a closer look at the latest news from the ASX 200 health insurance giant.

a woman in a business suit stands with her arms folded in the background of a statue of lady justice wearing robes, carrying a sword and holding the scales of justice.

Image source: Getty Images

Medibank faces shareholder class action

The Medibank share price appears not to have been impacted by news a shareholder class action against the company has been filed in the Supreme Court of Victoria.

The action alleges the company breached continuous disclosure obligations and ASX listing rules by not disclosing information related to alleged deficiencies in its cyber security systems.

Medibank intends to defend the action, understood to have been brought on behalf of investors who bought shares in Medibank between July 2019 and October 2022.

The law firm behind the legal action is United States-based Quinn Emanuel.

Medibank revealed it had been served with the action after the market closed on Wednesday.

The ASX 200 company bore $26.2 million of costs related to the cyber-attack last half.

It expects to fork out another $13.8 million to $18.8 million this half. That's before any potential remediation, regulatory, or litigation costs.

The shareholder class action is the second suit faced by the company as a result of the breach.

Medicare vowed to defend itself against a class action brought on behalf of current and former customers last month. It included allegations of breach of contract, contraventions of Australian consumer law, and breach of equitable obligations of confidence.

It was filed in the Federal Court of Australia and brought by law firm Baker McKenzie, funded by Omni Bridgeway.

Medibank share price snapshot

The Medibank share price tumbled 18% when the company revealed the cyber-attack in October, and it hasn't quite recovered yet. It remains 6% lower than it was prior to its ill-fated announcement.

Though, it has gained 6% over the last 12 months and 13% so far this year.

Comparatively, the ASX 200 has gained 3% year to date and has fallen 5% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks
Broker Notes

3 reasons to buy Pro Medicus shares today

Two leading investment analysts believe Pro Medicus shares are primed for a rebound.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Healthcare Shares

Should I invest $10,000 into CSL shares? Yes or no

Is it time to pick up this fallen giant? Let's dig deeper into things.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

ASX 200 healthcare shares down 33% in a year as heavyweights hit multi-year lows

Eight of the 10 largest healthcare shares are trading at or close to multi-year or 52-week lows.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Healthcare Shares

Up 2,075% in a year, why is the 4DMedical share price rocketing again on Friday?

Investors just sent 4DMedical shares surging another 20% on Friday. But why?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Healthcare Shares

Buy, hold, sell: What is Ord Minnett saying about this popular ASX 200 stock?

Here's what the broker is saying about this stock.

Read more »

A man in a shirt and tie looks to the horizon holding his hand above his eyes as if to shield the sun so he can see better.
Healthcare Shares

Why is everyone talking about 4DX shares this week?

It's all eyes on the healthcare stock this week.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

$10,000 invested in this ASX healthcare share a year ago is now worth $36,500

This stock has experienced a dramatic price increase.

Read more »